โครงการพัฒนาข้อเสนอเพื่อการปรับปรุงชุดสิทธิประโยชน์และระบบบริการด้านการสร้างเสริมสุขภาพและป้องกันโรค สำหรับปีงบประมาณ

This research and development project aims to (i) provide recommendations for development of the P&P policies for children aged 0-5 years old; (ii) develop mechanism for further development of the P&P policies for other groups of population that is systematic, evidence-based, transparent, participatory; (iii) establish health promotion and

Teenage pregnancy is an important issue. Many countries are paying attention to it. The policies in Thailand and the measures being taken to combat teenage pregnancy indicate that administrators and the public are taking the issue very seriously. Solving the problem of unwanted teenage pregnancy in Thailand was the first subject on the agenda of th

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in Thailand. Usa Chaikledkaew1,2 Chanida Lertpitakpong2 Yot Teerawattananon2 Montarat Thavorncharoensap1,2 Viroj Tangcharoensathien 3 1Department of Phar

20-208-2556collaboration project,Philippines,ความร่วมมือ

The Clinical Research Collaboration Network in collaboration with the HITAP conducted a clinical test of Randomized Controlled Trial (RCT) regarding the treatment of relapse or resistant proliferative lupus nephritis. The objective of this research was to determine the efficacy of enteric-coated Mycophenolate Sodium combined with corticosteroids fo

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide